SCM
Soleus Capital Management Portfolio holdings
AUM
$1.45B
1-Year Return
18.23%
This Quarter Return
+0.83%
1 Year Return
+18.23%
3 Year Return
+274.85%
5 Year Return
+440.77%
10 Year Return
–
AUM
$1.45B
AUM Growth
+$173M
(+14%)
Cap. Flow
+$220M
Cap. Flow
% of AUM
15.19%
Top 10 Holdings %
Top 10 Hldgs %
47.24%
Holding
102
New
27
Increased
19
Reduced
27
Closed
7
Top Buys
| 1 |
Krystal Biotech
KRYS
|
$66.1M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$34.8M |
| 3 |
UroGen Pharma
URGN
|
$29.9M |
| 4 |
Elevance Health
ELV
|
$27.2M |
| 5 |
UnitedHealth
UNH
|
$26.9M |
Top Sells
| 1 |
TG Therapeutics
TGTX
|
$21.7M |
| 2 |
Insmed
INSM
|
$20.3M |
| 3 |
Hologic
HOLX
|
$18.7M |
| 4 |
Merus
MRUS
|
$18.2M |
| 5 |
Madrigal Pharmaceuticals
MDGL
|
$18M |
Sector Composition
| 1 | Healthcare | 99.87% |
| 2 | Consumer Staples | 0.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
The Beauty Health Co
SKIN
$260M
| $1.91M | 0.13% |
+1,000,000
| New | +$1.91M |
|
|
MREO
77
Mereo BioPharma
MREO
$282M
| $1.63M | 0.11% |
599,711
-87,242
| -13% | -$236K |
|
78
Y-mAbs Therapeutics
YMAB
$390M
| $1.58M | 0.1% |
349,982
| – | – |
|
|
TECX
79
Tectonic Therapeutic, Inc. Common Stock
TECX
$314M
| $1.53M | 0.1% |
76,841
| – | – |
|
80
Myomo
MYO
$37.7M
| $1.52M | 0.1% |
704,275
| – | – |
|
81
CalciMedica
CALC
$43M
| $1.25M | 0.08% |
783,904
| – | – |
|
82
Edgewise Therapeutics
EWTX
$1.64B
| $1M | 0.07% |
76,493
+4,193
| +6% | +$55K |
|
83
OrthoPediatrics
KIDS
$524M
| $967K | 0.06% |
45,000
| – | – |
|
|
ABVX
84
Abivax
ABVX
$6.65B
| $956K | 0.06% |
125,000
| – | – |
|
|
CBLL
85
CeriBell, Inc. Common Stock
CBLL
$433M
| $937K | 0.06% |
+50,000
| New | +$937K |
|
86
Soleno Therapeutics
SLNO
$3.71B
| $838K | 0.06% |
10,000
-140,000
| -93% | -$11.7M |
|
|
SEPN
87
Septerna, Inc. Common Stock
SEPN
$643M
| $798K | 0.05% |
75,456
-675,897
| -90% | -$7.14M |
|
|
BCYC
88
Bicycle Therapeutics
BCYC
$496M
| $695K | 0.05% |
+100,000
| New | +$695K |
|
89
Adverum Biotechnologies
ADVM
$73.9M
| $618K | 0.04% |
287,246
| – | – |
|
90
Revolution Medicines
RVMD
$7.57B
| $368K | 0.02% |
10,000
-74,784
| -88% | -$2.75M |
|
91
Delcath Systems
DCTH
$408M
| $340K | 0.02% |
25,000
-207,722
| -89% | -$2.83M |
|
92
IO Biotech
IOBT
$128M
| $268K | 0.02% |
192,670
| – | – |
|
93
Axsome Therapeutics
AXSM
$6.25B
| $209K | 0.01% |
2,000
-15,000
| -88% | -$1.57M |
|
94
Adaptive Biotechnologies
ADPT
$1.96B
| $117K | 0.01% |
10,000
| – | – |
|
95
Apogee Therapeutics
APGE
$2.26B
| – | – |
-16,000
| Closed | -$598K |
|
|
96
Hologic
HOLX
$14.8B
| – | – |
-302,000
| Closed | -$18.7M |
|
97
LivaNova
LIVN
$3.17B
| – | – |
-117,040
| Closed | -$4.6M |
|
98
Protagonist Therapeutics
PTGX
$3.77B
| – | – |
-169,000
| Closed | -$8.17M |
|
99
Sanofi
SNY
$113B
| – | – |
-226,218
| Closed | -$12.5M |
|
100
Sarepta Therapeutics
SRPT
$1.96B
| – | – |
-58,000
| Closed | -$3.7M |
|